Premier Alternatives

Ten63 Therapeutics

Durham, NC · Founded 2018 · Privately Held (backing)

Developer of novel antineoplastic therapeutics designed to create remedial medicines to targets previously believed undruggable. Ten63 Therapeutics is based in Durham, NC and was founded in 2018. It was valued at $979 million at its later-stage round in Jan 2025, the last priced event on record. It has raised $50.5 million across 1 recorded round; the latest was a $2.1 million seed round in Jan 2021.

PMV mark · valuation
$979.0M
Oct 2026
Priced at
its later-stage round
Jan 2025
Total raised
$50.5M
Last round
Seed Round
Jan 2021

Ten63 Therapeutics key facts

as of Oct 2026
  • Developer of novel antineoplastic therapeutics designed to create remedial medicines to targets previously believed undruggable.
  • Ten63 Therapeutics is valued at approximately $979.0M as of Oct 2026, set at its later-stage round, Jan 2025; nothing has traded since, per PrivateMarketView’s mark.
  • It has raised $50.5M across 1 recorded rounds; the latest was Seed Round ($2.1M) in Jan 2021.
  • Notable investors include SOSV, Calm Ventures, Draper Associates, K5 Global, IndieBio — 20 tracked in total.
  • Ten63 Therapeutics has filed 1 Form D with the SEC, most recently Jan 2021 ($2.1M sold to 7 investors).
  • Status: Privately Held (backing).
PrivateMarketView mark
LOW confidence
$979.0M

Valued at $979.0M at its later-stage round, Jan 2025. Nothing has traded since.

set by its last priced roundas of Oct 2026question about this number?
Free account
More of Ten63 Therapeutics with a free account
  • ·The complete investor list: 20 names
  • ·Watch Ten63 Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Ten63 Therapeutics funding rounds

1 rounds
Jan 2021Seed Round$2.1MSEC filing▮
Full funding history →

Ten63 Therapeutics valuation

Ten63 Therapeutics was valued at $979 million at its later-stage round in Jan 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has Ten63 Therapeutics raised?

Ten63 Therapeutics has raised $50.5 million in total; 1 of its rounds is on record. The largest on record was a $2.1 million seed round in Jan 2021.

Ten63 Therapeutics has filed 1 Form D with the SEC, most recently in Jan 2021 ($2.1 million sold to 7 investors).

Ten63 Therapeutics investors

20 investors are on record for Ten63 Therapeutics, including SOSV, Calm Ventures, Draper Associates and K5 Global. By type, the record holds 8 venture capital firms. The seed round in Jan 2021 drew 7 investors.

About Ten63 Therapeutics

Developer of novel antineoplastic therapeutics designed to create remedial medicines to targets previously believed undruggable. The company's therapeutics are created using algorithms to build proprietary scaffold redesign and hopping technology, combining MOA and chemical design to achieve a more durable response, enabling drug researchers to screen trillions of molecules for resistance prediction and antibody redesign.

Sector
Healthcare
HQ
Durham, NC, United States
Founded
2018
Employees
29
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.